IPO
Tarsier Pharma Ltd.
Filed with the SEC to go public on Apr 21, 2026. Newest amendment Jul 16, 2026.
Terms
| Price range | US$8.00 to US$10.00 a share | |
| Shares offered | 5,555,555 ordinary shares | |
| Offering size | US$44.4 million to US$55.6 million | Shares offered times the price range, worked out by 6ix |
| Underwriters' option | Up to 833,333 more shares | |
| Listing | TARX on the New York Stock Exchange | Has applied to list |
| Underwriter | Konik Capital Partners |
From the cover of the amended prospectus (F-1/A) filed Jul 16, 2026
Steps
| Draft sent to the SEC in confidence | Dec 29, 2025 |
| Filed publicly | Apr 21, 2026 |
| Amended 5 times | Newest Jul 16, 2026 |
| Shares registered with an exchange | Not yet |
| Declared effective by the SEC | Not yet |
| Final prospectus, with the price | Not yet |
Filings
- Jul 16, 2026 F-1/A · Registration statement, amended
- Jul 15, 2026 F-1/A · Registration statement, amended
- Jun 16, 2026 F-1/A · Registration statement, amended
- Jun 8, 2026 F-1/A · Registration statement, amended
- May 18, 2026 FWP · Free writing prospectus
- May 18, 2026 F-1/A · Registration statement, amended
- Apr 21, 2026 F-1 · Registration statement
- Mar 31, 2026 DRS/A · Draft registration statement, amended
- Feb 24, 2026 DRS/A · Draft registration statement, amended
- Dec 29, 2025 DRS · Draft registration statement